Cnat stock news today
CNAT Stock | CONATUS PHARMACEUTICALS Stock Price Today ... CNAT: Get the latest Conatus Pharmaceuticals stock price and detailed information including CNAT news, historical charts and realtime prices. CNAT | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for CONATUS PHARMACEUTICALS INC (CNAT), including profile, stock chart, recent news and …
CNAT Price Target and Analyst Ratings (Conatus ...
CNAT -- Is Its Stock Price A Worthy Investment? Learn More. CNAT Stock Summary. CNAT has a market capitalization of $13,832,093 -- more than approximately just 5.84% of US stocks. For CNAT, its debt to operating expenses ratio is greater than that reported by merely 8.5% of US equities we're observing. CNAT Stock | CONATUS PHARMACEUTICALS Stock Price Today ... CNAT: Get the latest Conatus Pharmaceuticals stock price and detailed information including CNAT news, historical charts and realtime prices. CNAT | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for CONATUS PHARMACEUTICALS INC (CNAT), including profile, stock chart, recent news and … CNAT Stock Quote - Conatus Pharmaceuticals, Inc. Stock ...
Drug Stock Poised to Lose Half its Value After Dismal Data
CNET news editors and reporters provide top technology news, with investigative reporting and in-depth coverage of tech issues and events.
CNAT | Conatus Pharmaceuticals Inc. Advanced Charts ...
Technology News - CNET News - CNET CNET news editors and reporters provide top technology news, with investigative reporting and in-depth coverage of tech issues and events. Conatus Pharmaceuticals (CNAT) Stock Crashes After Trial ...
CNAT Stock Price and Chart — NASDAQ:CNAT — TradingView
Conatus Pharmaceuticals Inc. (CNAT) stock fell over 50% today amid disappointing results for the company’s 2b ENCORE-PH clinical trial in NASH cirrhosis.
Current stock quote for Conatus Pharmaceuticals Inc. ( CNAT ) including financial statements, level 2 data, and the latest Biotechnology news, research, and